Shelley Broader - Raymond James Non-Executive Independent Director
| RJF Stock | USD 168.92 1.87 1.12% |
Director
Ms. Shelley G. Broader is NonExecutive Independent Director of the Company. She is director, President and Chief Executive Officer of Chicos FAS, Inc. From June 2014 to November 2015, she was President and Chief Executive Officer of Walmart EMEA Region . From July 2014 to October 2015, she was a nonexecutive Director, member of the Nomination Committee, the Remuneration Committee, and the Risk and Audit Committee of Massmart Holdings Limited, Sandton, South Africa. She previously served as President and Chief Executive Officer of Walmart Canada from September 2011 to May 2014. From March 2011 to March 2013, she was a Director of WalMart de Mxico, which is publicly traded on the Mexican stock exchange. She was Chief Merchandising Officer of Walmart Canada Corporationration, from December 2010 to September 2011, and Senior Vice President, Sams Club, a division of WalMart Stores, Inc. from 2009 to 2010. She served as President and Chief Operating Officer of Michaels Stores, Inc. from 2008 to 2009, President and Chief Executive Officer, Sweetbay Supermarket, a division of Kash n Karry Food Stores, Inc., from 2006 to 2008, and President and Chief Executive Officer, Kash n Karry Food Stores, Inc. from 2003 to 2006. From 1991 to 2003, Ms. Broader held positions of increasing management responsibility at Hannaford Bros. Co., culminating in Senior Vice President, Business Strategy, Marketing and Communications. Her prior financial service industry experience includes Massachusetts Financial Services Company and Assistant Vice President at First Albany Corporationrationration. Ms. Broader is a member of the Board of Advisors of the H. Lee Moffitt Cancer Center Research Institute. since 2008.
| Age | 55 |
| Tenure | 16 years |
| Address | 880 Carillon Parkway, Saint Petersburg, FL, United States, 33716 |
| Phone | 727 567 1000 |
| Web | https://www.raymondjames.com |
Shelley Broader Latest Insider Activity
Tracking and analyzing the buying and selling activities of Shelley Broader against Raymond James stock is an integral part of due diligence when investing in Raymond James. Shelley Broader insider activity provides valuable insight into whether Raymond James is net buyers or sellers over its current business cycle. Note, Raymond James insiders must abide by specific rules, including filing SEC forms every time they buy or sell Raymond James'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Shelley Broader over three months ago Acquisition by Shelley Broader of 117 shares of Inspire Medical at 138.58 subject to Rule 16b-3 | ||
Shelley Broader over six months ago Acquisition by Shelley Broader of tradable shares of Inspire Medical at 231.74 subject to Rule 16b-3 |
Raymond James Management Efficiency
The company has Return on Asset of 0.024 % which means that on every $100 spent on assets, it made $0.024 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1935 %, implying that it generated $0.1935 on every 100 dollars invested. Raymond James' management efficiency ratios could be used to measure how well Raymond James manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0.02. The current Return On Capital Employed is estimated to decrease to 0.09. At this time, Raymond James' Total Current Assets are most likely to increase significantly in the upcoming years. The Raymond James' current Intangible Assets is estimated to increase to about 567.5 M, while Other Assets are projected to decrease to (16.8 B).Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Paul Friedman | Oppenheimer Holdings | 65 | |
| Sarah Williamson | Evercore Partners | 56 | |
| Robert Millard | Evercore Partners | 70 | |
| James Oates | Stifel Financial | 74 | |
| Richard Haass | Lazard | 68 | |
| David Ying | Evercore Partners | 69 | |
| Pamela Carlton | Evercore Partners | 66 | |
| Andrew Alper | Lazard | 62 | |
| Kenneth Whitney | PJT Partners | 63 | |
| Jeffrey Werbalowsky | Houlihan Lokey | N/A | |
| Simon Robertson | Evercore Partners | 79 | |
| Kathleen Brown | Stifel Financial | 74 | |
| Dennis Hersch | PJT Partners | 72 | |
| Todd Esq | Houlihan Lokey | 61 | |
| John Allison | Moelis Co | 71 | |
| Robert Grady | Stifel Financial | 62 | |
| Emily Rafferty | PJT Partners | 71 | |
| Michael Brown | Stifel Financial | 74 | |
| Paul Zuber | Houlihan Lokey | 60 | |
| Michelle Jarrard | Lazard | 52 | |
| Jane Mendillo | Lazard | 61 | |
Management Performance
| Return On Equity | 0.19 | ||||
| Return On Asset | 0.024 |
Raymond James Financial Leadership Team
Elected by the shareholders, the Raymond James' board of directors comprises two types of representatives: Raymond James inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Raymond. The board's role is to monitor Raymond James' management team and ensure that shareholders' interests are well served. Raymond James' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Raymond James' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Susan Story, Non-Executive Lead Independent Director | ||
| Jeffrey Edwards, Non-Executive Independent Director | ||
| Jennifer Ackart, Senior Vice President, Chief Accounting Officer, Controller | ||
| George Catanese, Senior Vice President Chief Risk Officer | ||
| Gordon Johnson, Non-Executive Independent Director | ||
| Paul Shoukry, Vice President - Finance and Investor Relations | ||
| Scott Curtis, President of Raymond James Financial Services, Inc | ||
| James Bunn, Co-President - Global Equities and Investment Banking - Raymond James & Associates, Inc. | ||
| Bella Allaire, Executive Vice President - Technology and Operations of Raymond James & Associates, Inc. | ||
| Roderick McGeary, Non-Executive Independent Director | ||
| Jonathan Oorlog, Senior Officer | ||
| John Carson, Pres and President of Raymond James Financial Fixed Income | ||
| Anne Gates, Non-Executive Independent Director | ||
| Vin Campagnoli, Chief Officer | ||
| Steve LaBarbera, Chief Officer | ||
| Steve Raney, President, Chief Executive Officer of Raymond James Bank, N.A. | ||
| Thomas James, Chairman of the Board | ||
| Steven Raney, Chairman Bank | ||
| Jonathan Santelli, Executive Vice President General Counsel, Secretary | ||
| Benjamin Esty, Non-Executive Independent Director | ||
| Katherine Larson, Chief Controller | ||
| Raj Seshadri, Non-Executive Independent Director | ||
| Robert Dutkowsky, Non-Executive Independent Director | ||
| JD Esq, General VP | ||
| Jeffrey Julien, CFO, Executive VP of Fin., Treasurer and Chairman of Raymond James Bank | ||
| Tashtego Elwyn, Chief Executive Officer and President - Raymond James & Associates, Inc | ||
| Larry Adam, Chief Officer | ||
| Francis Godbold, Vice Chairman of the Board | ||
| Andy Zolper, Chief Officer | ||
| Kristina Waugh, Senior FPA | ||
| Shelley Broader, Non-Executive Independent Director | ||
| Jodi Perry, President - Independent Contractor Division | ||
| Charles Arentschildt, Non-Executive Independent Director | ||
| Paul Allison, Chairman, President, Chief Executive Officer of Raymond James Ltd. | ||
| Jeffrey Dowdle, President - Asset Management Services of Raymond James & Associates, Inc. | ||
| Paul Reilly, CEO, Executive Director and Member of Securities Offerings Committee | ||
| Marlene Debel, Non-Executive Independent Director |
Raymond Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Raymond James a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | ||||
| Return On Asset | 0.024 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 24.32 B | ||||
| Shares Outstanding | 203.3 M | ||||
| Shares Owned By Insiders | 10.04 % | ||||
| Shares Owned By Institutions | 78.02 % | ||||
| Number Of Shares Shorted | 6.04 M | ||||
| Price To Earning | 16.08 X |
Currently Active Assets on Macroaxis
When determining whether Raymond James Financial is a strong investment it is important to analyze Raymond James' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Raymond James' future performance. For an informed investment choice regarding Raymond Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Raymond James Financial. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Investment Banking & Brokerage space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Raymond James. If investors know Raymond will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Raymond James listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.417 | Dividend Share 1.8 | Earnings Share 9.7 | Revenue Per Share 61.69 | Quarterly Revenue Growth 0.132 |
The market value of Raymond James Financial is measured differently than its book value, which is the value of Raymond that is recorded on the company's balance sheet. Investors also form their own opinion of Raymond James' value that differs from its market value or its book value, called intrinsic value, which is Raymond James' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Raymond James' market value can be influenced by many factors that don't directly affect Raymond James' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Raymond James' value and its price as these two are different measures arrived at by different means. Investors typically determine if Raymond James is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Raymond James' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.